[小正方颗粒联合京前康抑菌明胶治疗湿热瘀血型慢性前列腺炎:基于红外热成像的临床观察]。

Q4 Medicine 中华男科学杂志 Pub Date : 2024-06-01
Peng Ma, Qi Zhang, Gui-Feng Chang, Zu-Long Wang
{"title":"[小正方颗粒联合京前康抑菌明胶治疗湿热瘀血型慢性前列腺炎:基于红外热成像的临床观察]。","authors":"Peng Ma, Qi Zhang, Gui-Feng Chang, Zu-Long Wang","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the clinical efficacy of Xiaozheng Granules (XZG) combined with Jingqiankang Bacteriostatic Gelatin (JBG) on chronic prostatitis of the damp-heat and blood-stasis type based on infrared thermography (IRT).</p><p><strong>Methods: </strong>This study included 120 cases of chronic prostatitis with damp-heat and blood stasis treated in the First Affiliated Hospital of Henan University of Chinese Medicine with oral XZG (the control group, n = 60) or oral XZG combined with anal administration of JBG (the trial group, n = 60), both for 4 weeks. We obtained the NIH-CPSI and traditional Chinese medicine (TCM) syndrome scores of the patients, measured the temperatures in the belt-vessel, lower focal and inguinal regions by IRT before and after treatment, recorded the adverse reactions during the treatment, and compared them between the two groups of patients.</p><p><strong>Results: </strong>Compared with the baseline, the NIH-CPSI and TCM syndrome scores were significantly decreased in the two groups of patients after treatment (P < 0.05), even more significantly in the trial than in the control group (P < 0.05), and after 1 hour of treatment, the temperatures in the Xiajiao ([34.09 ± 0.34] vs [33.60 ± 0.40] ℃, P < 0.05) and the groin region ([34.49 ± 0.28] vs [33.78 ± 0.30] ℃, P < 0.05) were remarkably reduced in the trial group, but showed no significant change in the control group (Xiajiao region: [34.02 ± 0.29] vs [34.05 ± 0.26] ℃, P > 0.05; groin region: [34.54 ± 0.25] vs [34.51±0.22] ℃, P > 0.05). After 4 weeks of treatment, the temperatures in the Xiajiao and groin regions were even lower in the trial ([33.13 ± 0.41] ℃ and [33.21 ± 0.29] ℃) and the control group ([33.42±0.25] ℃ and [33.86±0.29] ℃) than the baseline and those after 1 hour of treatment (P < 0.05), and still more significantly in the former than in the latter group (P < 0.05). The total effectiveness rate was markedly higher in the trial group than in the control (88.14% vs 77.19%, P < 0.05), and no obvious adverse reactions were observed in neither group.</p><p><strong>Conclusion: </strong>XZG combined with JBG is a safe and effective treatment of chronic prostatitis with damp-heat and blood-stasis, which can significantly reduce the NIH-CPSI and TCM syndrome scores and IRT temperatures in the lower focal and inguinal regions of the patients.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"30 6","pages":"540-546"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Xiaozheng Granules combined with Jingqiankang Bacteriostatic Gelatin for chronic prostatitis with damp-heat and blood stasis: A clinical observation based on infrared thermography].\",\"authors\":\"Peng Ma, Qi Zhang, Gui-Feng Chang, Zu-Long Wang\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To evaluate the clinical efficacy of Xiaozheng Granules (XZG) combined with Jingqiankang Bacteriostatic Gelatin (JBG) on chronic prostatitis of the damp-heat and blood-stasis type based on infrared thermography (IRT).</p><p><strong>Methods: </strong>This study included 120 cases of chronic prostatitis with damp-heat and blood stasis treated in the First Affiliated Hospital of Henan University of Chinese Medicine with oral XZG (the control group, n = 60) or oral XZG combined with anal administration of JBG (the trial group, n = 60), both for 4 weeks. We obtained the NIH-CPSI and traditional Chinese medicine (TCM) syndrome scores of the patients, measured the temperatures in the belt-vessel, lower focal and inguinal regions by IRT before and after treatment, recorded the adverse reactions during the treatment, and compared them between the two groups of patients.</p><p><strong>Results: </strong>Compared with the baseline, the NIH-CPSI and TCM syndrome scores were significantly decreased in the two groups of patients after treatment (P < 0.05), even more significantly in the trial than in the control group (P < 0.05), and after 1 hour of treatment, the temperatures in the Xiajiao ([34.09 ± 0.34] vs [33.60 ± 0.40] ℃, P < 0.05) and the groin region ([34.49 ± 0.28] vs [33.78 ± 0.30] ℃, P < 0.05) were remarkably reduced in the trial group, but showed no significant change in the control group (Xiajiao region: [34.02 ± 0.29] vs [34.05 ± 0.26] ℃, P > 0.05; groin region: [34.54 ± 0.25] vs [34.51±0.22] ℃, P > 0.05). After 4 weeks of treatment, the temperatures in the Xiajiao and groin regions were even lower in the trial ([33.13 ± 0.41] ℃ and [33.21 ± 0.29] ℃) and the control group ([33.42±0.25] ℃ and [33.86±0.29] ℃) than the baseline and those after 1 hour of treatment (P < 0.05), and still more significantly in the former than in the latter group (P < 0.05). The total effectiveness rate was markedly higher in the trial group than in the control (88.14% vs 77.19%, P < 0.05), and no obvious adverse reactions were observed in neither group.</p><p><strong>Conclusion: </strong>XZG combined with JBG is a safe and effective treatment of chronic prostatitis with damp-heat and blood-stasis, which can significantly reduce the NIH-CPSI and TCM syndrome scores and IRT temperatures in the lower focal and inguinal regions of the patients.</p>\",\"PeriodicalId\":24012,\"journal\":{\"name\":\"中华男科学杂志\",\"volume\":\"30 6\",\"pages\":\"540-546\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华男科学杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华男科学杂志","FirstCategoryId":"3","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目的根据红外热像图(IRT)评价小青颗粒联合精谦康抑菌明胶(JBG)对湿热血瘀型慢性前列腺炎的临床疗效:本研究纳入河南中医药大学第一附属医院收治的120例湿热血瘀型慢性前列腺炎患者,采用口服XZG(对照组,n = 60)或口服XZG联合肛门给药JBG(试验组,n = 60)治疗,疗程均为4周。我们获得了患者的NIH-CPSI和中医证候评分,通过IRT测量了治疗前后带脉、下焦和腹股沟区域的温度,记录了治疗期间的不良反应,并对两组患者进行了比较:与基线相比,两组患者治疗后NIH-CPSI和中医综合征评分均明显下降(P<0.05),试验组甚至明显高于对照组(P<0.05),治疗1小时后,下焦温度([34.09±0.34] vs [33.60±0.40] ℃,P<0.05)和腹股沟区([34.49 ± 0.28] vs [33.78 ± 0.30] ℃,P<0.05)明显降低,但对照组无明显变化(下焦区:[34.02±0.29] vs [34.05±0.26]℃,P>0.05;腹股沟区:[34.54±0.25] vs [34.51±0.22]℃,P>0.05)。治疗4周后,试验组下焦和腹股沟区温度更低([33.13±0.41] ℃和[33.21±0.29] ℃),对照组([33.42±0.25] ℃和 [33.86±0.29] ℃)均高于基线值和治疗1小时后(P<0.05),且前者仍明显高于后者(P<0.05)。试验组的总有效率明显高于对照组(88.14% vs 77.19%,P < 0.05),两组均未观察到明显的不良反应:结论:XZG联合JBG治疗慢性前列腺炎湿热血瘀证安全有效,可显著降低患者NIH-CPSI、中医综合征评分及下焦、腹股沟区IRT温度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[Xiaozheng Granules combined with Jingqiankang Bacteriostatic Gelatin for chronic prostatitis with damp-heat and blood stasis: A clinical observation based on infrared thermography].

Objective: To evaluate the clinical efficacy of Xiaozheng Granules (XZG) combined with Jingqiankang Bacteriostatic Gelatin (JBG) on chronic prostatitis of the damp-heat and blood-stasis type based on infrared thermography (IRT).

Methods: This study included 120 cases of chronic prostatitis with damp-heat and blood stasis treated in the First Affiliated Hospital of Henan University of Chinese Medicine with oral XZG (the control group, n = 60) or oral XZG combined with anal administration of JBG (the trial group, n = 60), both for 4 weeks. We obtained the NIH-CPSI and traditional Chinese medicine (TCM) syndrome scores of the patients, measured the temperatures in the belt-vessel, lower focal and inguinal regions by IRT before and after treatment, recorded the adverse reactions during the treatment, and compared them between the two groups of patients.

Results: Compared with the baseline, the NIH-CPSI and TCM syndrome scores were significantly decreased in the two groups of patients after treatment (P < 0.05), even more significantly in the trial than in the control group (P < 0.05), and after 1 hour of treatment, the temperatures in the Xiajiao ([34.09 ± 0.34] vs [33.60 ± 0.40] ℃, P < 0.05) and the groin region ([34.49 ± 0.28] vs [33.78 ± 0.30] ℃, P < 0.05) were remarkably reduced in the trial group, but showed no significant change in the control group (Xiajiao region: [34.02 ± 0.29] vs [34.05 ± 0.26] ℃, P > 0.05; groin region: [34.54 ± 0.25] vs [34.51±0.22] ℃, P > 0.05). After 4 weeks of treatment, the temperatures in the Xiajiao and groin regions were even lower in the trial ([33.13 ± 0.41] ℃ and [33.21 ± 0.29] ℃) and the control group ([33.42±0.25] ℃ and [33.86±0.29] ℃) than the baseline and those after 1 hour of treatment (P < 0.05), and still more significantly in the former than in the latter group (P < 0.05). The total effectiveness rate was markedly higher in the trial group than in the control (88.14% vs 77.19%, P < 0.05), and no obvious adverse reactions were observed in neither group.

Conclusion: XZG combined with JBG is a safe and effective treatment of chronic prostatitis with damp-heat and blood-stasis, which can significantly reduce the NIH-CPSI and TCM syndrome scores and IRT temperatures in the lower focal and inguinal regions of the patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
中华男科学杂志
中华男科学杂志 Medicine-Medicine (all)
CiteScore
0.40
自引率
0.00%
发文量
5367
期刊介绍: National journal of andrology was founded in June 1995. It is a core journal of andrology and reproductive medicine, published monthly, and is publicly distributed at home and abroad. The main columns include expert talks, monographs (basic research, clinical research, evidence-based medicine, traditional Chinese medicine), reviews, clinical experience exchanges, case reports, etc. Priority is given to various fund-funded projects, especially the 12th Five-Year National Support Plan and the National Natural Science Foundation funded projects. This journal is included in about 20 domestic databases, including the National Science and Technology Paper Statistical Source Journal (China Science and Technology Core Journal), the Source Journal of the China Science Citation Database, the Statistical Source Journal of the China Academic Journal Comprehensive Evaluation Database (CAJCED), the Full-text Collection Journal of the China Journal Full-text Database (CJFD), the Overview of the Chinese Core Journals (2017 Edition), and the Source Journal of the Top Academic Papers of China's Fine Science and Technology Journals (F5000). It has been included in the full text of the American Chemical Abstracts, the American MEDLINE, the American EBSCO, and the database.
期刊最新文献
[Clinical significance of prostatic exosomal protein and PSA in detecting prostate cancer with the PSA gray zone and PI-RADS-3 lesions]. [Effect of dietary modification-assisted multimodal therapy on chronic prostatitis]. [Effect of Xiongcan Yishen Formula on ferroptosis in mouse TM3 Leydig cells after oxidative stress injury]. [Electrophysiological technique for treatment of chronic prostatiti: Curative effect observation]. [Ferroptosis in the testis: Progress in research].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1